In this study, we have established that HSV-2 manipulates the intermediates of the PI3K/AKT/mTOR pathway through cellular miRNAs that not only have the potential to restrict HSV-2 pathogenesis but also contribute to the overall health of the host by alleviating other HSV-2 related pathologies and infections (Figure 8). Here, MTOR is linked to infection.